A critical breakthrough in cancer research is arising with the use of mini-antibodies to re-engage damaged p53. This crucial cancer suppressor protein is frequently inactivated in various kinds of cancer, resulting https://bookmarkja.com/story24841205/vhh-fragments-reactivate-the-p53-protein-the-potential-hope-for-malignant-therapy